ORLUMET

Orlumet, LLC, provides effective solutions that enhance the quality of human health. The Company’s portfolio consists of three innovative biomedical platform technologies co-developed by Dr. Peder Jensen, an oral surgeon with over 24 years of experience placing dental implants, and Dr. Alexandru Biris, Chief Scientist at the University of Arkansas at Little Rock’s Nanotechnology Center: (1) SC Platform: Bioactive surface coatings for medical devices. (2) DD Platform: Technology that enables localized delivery of drugs and antibiotics. (3) TE Platform: Biocompatible, bioresorbable matrices for tissue regeneration. Orlumet is currently in the pre-launch phase for its surface coatings platform, which is the fastest to market of the three platforms.